Answers are grounded in this paper and cite their sources.
Analysis evaluates the impact of calcimimetics on other medications in chronic kidney disease patients, suggesting influence on prescription patterns.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Miyake et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: